SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action?

Authors	Paulus S Rommer, Gabriel Bsteh, Thomas Berger, Uwe Klaus Zettl
Journal	Multiple sclerosis (Houndmills, Basingstoke, England) (Mult Scler) Vol. 28 Issue 1 Pg. 165-167 (01 2022) ISSN: 1477-0970 [Electronic] England
PMID	34387536 (Publication Type: Letter, Research Support, Non-U.S. Gov't, Comment)
Chemical References	Antibodies, Viral Vaccines
Topics	Antibodies, Viral COVID-19 Humans Multiple Sclerosis SARS-CoV-2 Vaccines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!